Bruce Booth
InvestorPartner at Atlas Venture · Board director at Vigil Neuroscience · Board director at Unum Therapeutics
Wellesley, MA
Writes $500K – $5M checks · typically $2M
About
Bruce Booth is a partner at Atlas Venture focused on the discovery and development of novel medicines and therapeutic platforms. He joined Atlas in 2005 after working as a consultant at McKinsey & Company and as an investor for Caxton Health Holdings. He holds a D.Phil. in molecular immunology from Oxford University, which he attended as a British Marshall Scholar, and a BS in biochemistry from The Pennsylvania State University.
Contact· published on Bruce's own website
Invests in
Biotech
Board director at Vigil Neuroscience
Intro paths
In turn, Bruce can intro founders to Vigil Neuroscience's investors below.
Board director at Unum Therapeutics
Intro paths
In turn, Bruce can intro founders to Unum Therapeutics's investors below.
Unum Therapeutics's investors · 2
Co-founders at Unum Therapeutics
Investments
Board seats
AvilaHotspot TherapeuticsKymera TherapeuticsLifordi ImmunotherapeuticsLysosomal TherapeuticsMatchpoint TherapeuticsNimbus LakshmiPadlock TherapeuticsRodin TherapeuticsSionna TherapeuticsSpolia TherapeuticsStromedixVigil Neuroscience
Investor
Nimbus Therapeutics
Per the firm's website.
Colleagues at Atlas Venture
Network6
Investors connected to Bruce in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Bruce Booth?
- Bruce Booth is a partner at Atlas Venture focused on the discovery and development of novel medicines and therapeutic platforms. He joined Atlas in 2005 after working as a consultant at McKinsey & Company and as an investor for Caxton Health Holdings. He holds a D.Phil. in molecular immunology from Oxford University, which he attended as a British Marshall Scholar, and a BS in biochemistry from The Pennsylvania State University.
- Where does Bruce Booth work?
- Bruce Booth is Partner at Atlas Venture and Board director at Vigil Neuroscience and Board director at Unum Therapeutics.
- What does Bruce Booth invest in?
- Bruce Booth invests in Biotech.
- What check size does Bruce Booth write?
- Bruce Booth typically writes checks of $500K – $5M.
- What boards does Bruce Booth sit on?
- Bruce Booth holds tracked board seats at Avila, Hotspot Therapeutics, Kymera Therapeutics, Lifordi Immunotherapeutics, Lysosomal Therapeutics, Matchpoint Therapeutics, Nimbus Lakshmi, Padlock Therapeutics, Rodin Therapeutics, Sionna Therapeutics.
- What companies has Bruce Booth invested in?
- Investments tracked here include Nimbus Therapeutics.